Prices via Intrinio. Supplier and customer ties are extracted from SEC filings and carry the sentence they came from. Not investment advice.
Prices via Intrinio. Supplier and customer ties are extracted from SEC filings and carry the sentence they came from. Not investment advice.
Oruka Therapeutics, Inc.
Price, suppliers and customers from SEC filings, institutional ownership and the next report.
Pharmaceutical Preparations
No intraday reading yet this session.
257 institutional managers report a position in Oruka Therapeutics, Inc. worth $7.1B between them, filed on form 13F for the quarter ending 2026-06-30. 30 of them hold 80% of it, the largest being FMR LLC at 12.16%.
232 more managers in the register
30 managers hold 80% of the $7.1B institutional base. The other 227 hold the rest.
Positions as filed with the SEC for the quarter ended Jun 30. A 13F is due 45 days after the quarter closes, so this register is 78 days old and does not move with the price above it.
ORKA (Oruka Therapeutics, Inc.) has 0 disclosed suppliers and 0 disclosed customers, strongest disclosure first.
Select a tie for the filing sentence that discloses it; select again to open the company. Lines are disclosed suppliers and customers, coloured by industry; the closer to the centre, the more the filings disclose. A dot is green or red by today’s move. Extended: satellites hang off single companies, not bundled sectors.
via Fairmount Funds Management LLC, VR Adviser, LLC, Paradigm Biocapital Advisors LP +13 more · 4.98% of ORKA, 6.24% of JBIO
via VR Adviser, LLC, Fairmount Funds Management LLC, Bellevue Group AG +10 more · 5.57% of ORKA, 5.60% of DMRA
via RTW Investments, LLC, VR Adviser, LLC, Paradigm Biocapital Advisors LP +16 more · 4.22% of ORKA, 4.40% of SYRE
via RTW Investments, LLC, Paradigm Biocapital Advisors LP, Deep Track Capital, LP +13 more · 4.22% of ORKA, 6.49% of TNGX
via VR Adviser, LLC, RTW Investments, LLC, Paradigm Biocapital Advisors LP +7 more · 5.57% of ORKA, 6.19% of ERAS
via Fairmount Funds Management LLC, VR Adviser, LLC, Polar Capital Holdings Plc +16 more · 4.98% of ORKA, 3.83% of DNTH
Managers holding a meaningful stake in ORKA also hold this much of the other company’s institutional base. Managers who hold most of the companies we cover are excluded, because their overlap says nothing about this one in particular. This is how the two are held, not evidence that one moves the other.